Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same

Details for Australian Patent Application No. 2002219166 (hide)

Owner AVENTIS PHARMA DEUTSCHLAND GMBH

Inventors Lang, Hans-Jochen; Heinelt, Uwe; Wirth, Klaus; Jansen, Hans-Willi

Agent Watermark

Pub. Number AU-A-2002219166

PCT Pub. Number WO2002/066431

Priority 100 63 294.7 19.12.00 DE

Filing date 7 December 2001

Wipo publication date 4 September 2002

International Classifications

C07D 213/38 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 031/44 - Non-condensed pyridines

C07D 307/52 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

C07D 333/20 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61K 031/381 - having five-membered rings

C07D 233/64 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 031/417

C07D 207/335 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07D 277/28 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/426 - 1,3-Thiazoles

C07D 241/12 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 031/4965 - Non-condensed pyrazines

C07D 239/26 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 031/505 - Pyrimidines

C07D 237/08 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 031/50 - Pyridazines

C07D 231/12 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/10 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 031/415 - 1,2-Diazoles

C07D 333/28 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/44 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 231/16 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 261/18 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-A-2002219166

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002219167-Control method for use in a toll determination system

2002219165